PMID- 31190161 OWN - NLM STAT- MEDLINE DCOM- 20200330 LR - 20200330 IS - 1433-7339 (Electronic) IS - 0941-4355 (Linking) VI - 28 IP - 3 DP - 2020 Mar TI - Personalized goal for insomnia and clinical response in advanced cancer patients. PG - 1089-1096 LID - 10.1007/s00520-019-04912-z [doi] AB - AIM: The aim of this study was to assess the Personalized Insomnia Intensity Goal (PIIG), the achievement of Personalized Goal Response (PGR), and Patient Global Impression (PGI) after a comprehensive symptom management. PATIENTS AND METHODS: Advanced cancer patients admitted to palliative care units rated pain and symptoms intensity and their PIIG by using the Edmonton Symptom Assessment Score (ESAS) (T0). In patients with significant levels of insomnia, the achievement of target expected (PIIG) was measured (patient goal response, PIGR), as well the patient global impression (PGI), by the minimal clinically important difference (MCID), after a comprehensive symptom management (T7). RESULTS: Three hundred ninety-seven patients with a level of insomnia of >/= 3 on ESAS were analyzed in this study. The mean values of PIIG at T0 and T7 were 1.2 (SD 1.5) and 0.9 (SD 1.4), respectively. Most patients (n = 406, 89.8%) indicated a PIIG of